Role of Intravenous Iron Therapy in Anemia Management: State of the Art

Seminars in Hematology

Volumn 43, Issue SUPPL. 6, 2006, Pages S1-

  Beris, Photis ^a   Maniatis, Alice ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; IRON; TRANSFERRIN;

ANEMIA; EDITORIAL; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; PREGNANCY; PRIORITY JOURNAL;

EID: 33749256136     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2006.08.001     Document Type: Editorial

References (14)

1. Ganz T., and Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 290 (2006) G199-G203
2. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
3. Beris P. The use of iron to increase red cell mass. Can J Anaesth 50 suppl (2003) S3-S9
4. Goodnough L.T., Skikne B., and Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 96 (2000) 823-833
5. National Kidney Foundation Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47 suppl 3 (2006) S1-S145
6. Locatelli F., Aljama P., Barany P., Canaud B., Carrera F., Eckardt K.U., et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19 suppl 2 (2004) ii1-ii47
7. Macdougall I.C., and Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: A prospective evaluation of 2,297 injections. Am J Kidney Dis 46 (2005) 283-289
8. Auerbach M., Ballard H., Trout J.R., McIlwain M., Ackerman A., Bahrain H., et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 22 (2004) 1301-1307
9. Schröder O., Mickisch O., Seidler U., de Weerth A., Dignass A.U., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-A randomized, controlled, open-label, multicenter study. Am J Gastroenterol 100 (2005) 2503-2509
10. Piagnerelli M., and Vincent J.L. Role of iron in anaemic critically ill patients: It's time to investigate!. Crit Care 8 (2004) 306-307
11. Breymann C., Richter C., Huttner C., Huch R., and Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 30 (2000) 154-161
12. Breymann C., Visca E., Huch R., and Huch A. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol 184 (2001) 662-667
13. Cuenca J., Garcia-Erce J.A., Martinez A.A., Solano V.M., Molina J., and Munoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: Preliminary data. Arch Orthop Trauma Surg 125 (2005) 342-347
14. Garcia-Erce J.A., Cuenca J., Munoz M., Izuel M., Martinez A.A., Herrera A., et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 88 (2005) 235-243